Daniel Geller

Dr. Daniel Geller


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2004 in Acta Psychiatrica Scandinavica
Verified
Journal Article
Closed access
PDF file
SSS. Evelyn Stewart
S. Evelyn Stewart
DGDaniel Geller
Daniel Geller
MJM. Jenike
M. Jenike
DPD. Pauls
D. Pauls
DSD. Shaw
D. Shaw
SFStephen V. V Faraone
Stephen V. V Faraone

1 November 2003 in American Journal of Psychiatry
Verified
Journal Article
Closed access
DGDaniel Geller
Daniel Geller
JBJoseph Biederman
Joseph Biederman
SSS. Evelyn Stewart
S. Evelyn Stewart
BMBenjamin Mullin
Benjamin Mullin
AMAndrés Martin
Andrés Martin
SFStephen V. V Faraone
Stephen V. V Faraone

1 September 2007 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
DGDaniel Geller
Daniel Geller
CDCraig Donnelly
Craig Donnelly
FLFrank Lopez
Frank Lopez
RRRichard Rubin
Richard Rubin
JNJeffrey Newcorn
Jeffrey Newcorn
CSCalvin Sumner
Calvin Sumner

1 November 2004 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
DGDaniel Geller
Daniel Geller
KWKaren Dineen Wagner
Karen Dineen Wagner
GEGraham Emslie
Graham Emslie
TMTanya Murphy
Tanya Murphy
DCDavid J. Carpenter
David J. Carpenter
CGChristel Gardiner
Christel Gardiner

1 July 2003 in Journal of Child and Adolescent Psychopharmacology
Verified
Journal Article
Closed access
DGDaniel Geller
Daniel Geller
JBJoseph Biederman
Joseph Biederman
SSS. Evelyn Stewart
S. Evelyn Stewart
BMBenjamin Mullin
Benjamin Mullin
CFColleen Farrell
Colleen Farrell
DCDavid Carpenter
David Carpenter
Objective: To examine the influence of psychiatric comorbidity on response and relapse rates in children and adolescents treated with paroxetine for obsessive-compulsive disorder (OCD). Methods: Patients responding following 16 weeks of treatment (phase I) were randomized to continued paroxetine or to placebo for 16 additional weeks (phase II). OCD response (phase I) and relapse (phase II) criteria were based on the Clinical Global Impression-Improvement Scale and the Children's Yale-Brown Obsessive Compulsive Scale. The presence of OCD and other psychiatric disorders was ascertained using the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version interview. Results: At entry, 193 of 335 (57.6%) patients had at least one psychiatric disorder in addition to OCD, and 102 of 335 (30.4%) had multiple other disorders. Although the response rate to paroxetine in the overall population was high (71%), the response rates in patients with comorbid attention deficit hyperactivity disorder, tic disorder, or oppositional defiant disorder (56%, 53%, and 39%, respectively) were significantly less than in patients with OCD only (75%) (intent-to-treat population, last observation carried forward analysis, p < 0.05). Psychiatric comorbidity was associated with a greater rate of relapse in the total patient population (46% for one or more comorbid disorders [p = 0.04] and 56% for two or more comorbid disorders [p < 0.05] vs. 32% for no comorbidity). Conclusions: The results of these post hoc analyses show that comorbid illness adversely impacted response to pharmacotherapy with paroxetine in pediatric OCD and significantly increased risk of relapse following withdrawal from treatment. Continued paroxetine treatment reduced the relapse rates in all groups compared with placebo, including those with comorbid illness. Because pediatric OCD is frequently comorbid with other psychiatric disorders, results of randomized, controlled pediatric OCD trials that use multiple exclusion criteria may not generalize to more naturalistic OCD samples.

1 February 2007 in Biological Psychiatry
Verified
Journal Article
Closed access
DGDaniel Geller
Daniel Geller
CPCarter Petty
Carter Petty
FVFe Vivas
Fe Vivas
JJJessica Johnson
Jessica Johnson
DPDavid Pauls
David Pauls
JBJoseph Biederman
Joseph Biederman